Abstract:Affinity chromatography is one of the most common techniques employed at the industrial-scale for antibody purification. In particular, the purification of human immunoglobulin G (hIgG) has gained relevance with the immobilization of its natural binding counterpart—Staphylococcus aureus Protein A (SpA) or with the recent development of biomimetic affinity ligands, namely triazine-based ligands. These ligands have been developed in order to overcome economic and leaching issues associated to SpA. The most recent triazine-based ligand—TPN-BM, came up as an analogue of 2-(3-amino-phenol)-6-(4-amino-1-naphthol)-4-chloro-sym-triazine ligand also known as ligand 22/8 with improved physico-chemical properties and a greener synthetic route. This work intends to evaluate the potential of TPN-BM as an alternative affinity ligand towards antibody recognition and binding, namely IgG, at an atomic level, since it has already been tested, after immobilization onto chitosan-based monoliths and demonstrated interesting affinity behaviour for this purpose. Herein, combining automated molecular docking and molecular dynamics simulations it was predicted that TPN-BM has high propensity to bind IgG through the same binding site found in the crystallographic structure of SpA_IgG complex, as well as theoretically predicted for ligand 22/8_IgG complex. Furthermore, it was found that TPN-BM established preferential interactions with aromatic residues at the Fab domain (Trp 50, Tyr 53, Tyr 98 and Trp 100), while in the Fc domain the main interactions are based on hydrogen bonds with pH sensitive residues at operational regime for binding and elution like histidines (His 460, His 464, His 466). Moreover, the pH dependence of TPN-BM_IgG complex formation was more evident for the Fc domain, where at pH 3 the protonation state and consequently the charge alteration of histidine residues located at the IgG binding site induced ligand detachment which explains the optimal elution condition at this pH observed experimentally.

Stabilization of the Divalent HLA-A2/IgG1 Molecule during Acidical Elution by Covalent Association of β2m with HLA-A2/IgG1 Molecule

Development of a Hybrid Biomimetic Ligand with High Selectivity and Mild Elution for Antibody Purification

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

A New Tetrapeptide Biomimetic Chromatographic Resin for Antibody Separation with High Adsorption Capacity and Selectivity

Molecular Insights into the Binding Selectivity of a Synthetic Ligand DAAG to Fc Fragment of IgG

Evaluation on Adsorption Selectivity of Immunoglobulin G with 2-Mercapto-1-methyl-imidazole-based Hydrophobic Charge-Induction Resins

Enhancing monoclonal antibody stability during protein a chromatography using 2-methyl imidazolium dihydrogen phosphate

Characterization of Immunoglobulin Adsorption on Dextran-Grafted Hydrophobic Charge-Induction Resins: Cross-effects of Ligand Density and Ph/salt Concentration

In vitro expression and purification of heavy chain and β_2m of soluble HLA-G1

Stability enhancement in a mAb and Fab coformulation

Engineering an Improved IgG4 Molecule with Reduced Disulfide Bond Heterogeneity and Increased Fab Domain Thermal Stability

In Vitro Expression and Purification of Heavy Chain and Β2m of Soluble HLA-G1

Structural evaluation of an alternative Protein A biomimetic ligand for antibody purification

Stabilizing Two IgG1 Monoclonal Antibodies by Surfactants: Balance Between Aggregation Prevention and Structure Perturbation

Interchain Disulfide Bonding in Human IgG2 Antibodies Probed by Site-Directed Mutagenesis

Refolding and identification of soluble HLA-G1-peptide complex in vitro

Improving the Stability of an Antibody Variable Fragment by a Combination of Knowledge-based Approaches: Validation and Mechanisms

Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region

In-vitro refolding and biotinylation of soluble HLA-A2-peptide complex]

Cloning, expression, and purification of HLA-A2-BSP and β-2m in Escherichia coli

N-terminal Truncation of an Isolated Human IgG1 CH2 Domain Significantly Increases Its Stability and Aggregation Resistance.